ROYAL BANK OF CANADA - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 45 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$6,0000.0%6,0000.0%0.00%
Q2 2021$6,0000.0%6,0000.0%0.00%
Q1 2021$6,000
-14.3%
6,0000.0%0.00%
Q4 2020$7,000
+16.7%
6,0000.0%0.00%
Q3 2020$6,000
-14.3%
6,0000.0%0.00%
Q2 2020$7,000
+16.7%
6,0000.0%0.00%
Q1 2020$6,000
-99.7%
6,000
-99.7%
0.00%
-100.0%
Q4 2019$2,289,000
+38050.0%
2,001,000
+33250.0%
0.00%
Q1 2018$6,0000.0%6,0000.0%0.00%
Q4 2017$6,000
-25.0%
6,000
-25.0%
0.00%
Q3 2017$8,000
+33.3%
8,000
+33.3%
0.00%
Q2 2017$6,000
+200.0%
6,000
+200.0%
0.00%
Q1 2017$2,0000.0%2,0000.0%0.00%
Q4 2016$2,0000.0%2,0000.0%0.00%
Q3 2016$2,000
+100.0%
2,0000.0%0.00%
Q2 2016$1,0002,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2017
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders